HUNT JONATHAN ROBERT (Chief Financial Officer) purchased 35.7% of their position (12.83K shares) of PERSPECTIVE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $49.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 4 purchases
Filed: 11/27/2024ACC: 0000950170-24-131250
Officer· Chief Financial Officer
Since Dec 2018
+12.83K
Net shares
Net buyer
$49.0K
Total acquired
4
Open market trades
4B · 0S
4
Total transactions
12.83K acquired
Non-Derivative Transactions4
Common Stock
Direct
Shares
+400.00
Price / share
$3.55
Trade value
$1.42K
% of position
1.1%
11/25/2024
35.97K→36.37K
Common Stock
Direct
Shares
+29.00
Price / share
$3.94
Trade value
$114.26
% of position
0.1%
11/25/2024
36.37K→36.40K
Common Stock
Direct
Shares
+2.40K
Price / share
$3.60
Trade value
$8.64K
% of position
6.6%
11/25/2024
36.40K→38.80K
Common Stock
Direct
Shares
+10K
Price / share
$3.88
Trade value
$38.80K
% of position
25.8%
11/25/2024
38.80K→48.80K
Total
Net shares
+12.83K
Net value
$48.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/25/2024 | P · Purchase | +400.00 | $3.55 | $1.42K | 1.1% | 35.97K | 36.37K |
| Common Stock Direct | 11/25/2024 | P · Purchase | +29.00 | $3.94 | $114.26 | 0.1% | 36.37K | 36.40K |
| Common Stock Direct | 11/25/2024 | P · Purchase | +2.40K | $3.60 | $8.64K | 6.6% | 36.40K | 38.80K |
| Common Stock Direct | 11/25/2024 | P · Purchase | +10K | $3.88 | $38.80K | 25.8% | 38.80K | 48.80K |
| Total | +12.83K | $48.97K | ||||||
Derivative Transactions0
No derivative transactions reported